Literature DB >> 3335536

Comparative study of the mucin-type sugar chains of human chorionic gonadotropin present in the urine of patients with trophoblastic diseases and healthy pregnant women.

J Amano1, R Nishimura, M Mochizuki, A Kobata.   

Abstract

Human chorionic gonadotropins (hCGs) highly purified from the urine of patients with trophoblastic diseases and of healthy pregnant women contain approximately four mucin-type sugar chains in one molecule. The structures of these sugar chains were studied comparatively by using a new sensitive method to obtain mucin-type sugar chains quantitatively as radioactive oligosaccharides from a small amount of glycoproteins. The mucin-type sugar chains of all hCGs include sialylated and nonsialylated Gal beta 1----3GalNAc and Gal beta 1----4GlcNAc beta 1----6(Gal beta 1----3)GalNAc. In the case of normal hCG and hydatidiform mole hCG, oligosaccharides containing the tetrasaccharide core occupy approximately 10% of the total mucin-type sugar chains. The ratio of the tetrasaccharide containing oligosaccharides is increased prominently to approximately 60% in choriocarcinoma hCG. The proportion in invasive mole hCG was also increased, but less than the proportion of choriocarcinoma hCG.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3335536

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

Review 1.  Molecular structures of glycoprotein hormones and functions of their carbohydrate components.

Authors:  A Stockell Hartree; A G Renwick
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

Review 2.  Functional aspects of glycoprotein N-linked oligosaccharide processing by human tumours.

Authors:  C S Foster
Journal:  Br J Cancer Suppl       Date:  1990-07

3.  Characterization of the O-linked oligosaccharide structures on P-selectin glycoprotein ligand-1 (PSGL-1).

Authors:  P A Aeed; J G Geng; D Asa; L Raycroft; L Ma; A P Elhammer
Journal:  Glycoconj J       Date:  1998-10       Impact factor: 2.916

4.  Characterization of the N-linked oligosaccharides from human chorionic gonadotropin expressed in the methylotrophic yeast Pichia pastoris.

Authors:  Véronique Blanchard; Rupali A Gadkari; Gerrit J Gerwig; Bas R Leeflang; Rajan R Dighe; Johannis P Kamerling
Journal:  Glycoconj J       Date:  2007-01       Impact factor: 2.916

5.  Competition between core-2 GlcNAc-transferase and ST6GalNAc-transferase regulates the synthesis of the leukocyte selectin ligand on human P-selectin glycoprotein ligand-1.

Authors:  Chi Y Lo; Aristotelis Antonopoulos; Rohitesh Gupta; Jun Qu; Anne Dell; Stuart M Haslam; Sriram Neelamegham
Journal:  J Biol Chem       Date:  2013-04-02       Impact factor: 5.157

6.  Carbohydrate and peptide structure of the alpha- and beta-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma.

Authors:  M M Elliott; A Kardana; J W Lustbader; L A Cole
Journal:  Endocrine       Date:  1997-08       Impact factor: 3.633

7.  Purification and characterization of the MUC1 mucin-type glycoprotein, epitectin, from human urine: structures of the major oligosaccharide alditols.

Authors:  V P Bhavanandan; Q Zhu; K Yamakami; N A Dilulio; S Nair; C Capon; J Lemoine; B Fournet
Journal:  Glycoconj J       Date:  1998-01       Impact factor: 2.916

8.  Determination of hyperglycosylated human chorionic gonadotropin produced by malignant gestational trophoblastic neoplasias and male germ cell tumors using a lectin-based immunoassay and surface plasmon resonance.

Authors:  Lisa S Kelly; Steven Birken; David Puett
Journal:  Mol Cell Endocrinol       Date:  2006-11-01       Impact factor: 4.102

Review 9.  New discoveries on the biology and detection of human chorionic gonadotropin.

Authors:  Laurence A Cole
Journal:  Reprod Biol Endocrinol       Date:  2009-01-26       Impact factor: 5.211

Review 10.  Exploration of the Sialic Acid World.

Authors:  Roland Schauer; Johannis P Kamerling
Journal:  Adv Carbohydr Chem Biochem       Date:  2018-11-28       Impact factor: 12.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.